Drug intelligence / Profile preview

anrikefon

Development stage
Unknown
Lead developer
Haisco Pharmaceutical Group
Modality
Small Molecules
Administration
Intravenous
01

Overview

Anrikefon (HSK21542) is a peripherally restricted kappa-opioid receptor (KOR) agonist developed by Haisco Pharmaceutical Group. It is designed to provide potent analgesia and anti-pruritic effects by selectively activating KORs on peripheral sensory neurons, thereby avoiding the central nervous system (CNS) side effects—such as respiratory depression, sedation, and dysphoria—common to mu-opioid agonists and centrally acting KOR agonists. The drug is currently under clinical investigation for the management of postoperative pain and chronic kidney disease-associated pruritus (CKD-aP). Due to its peripherally restricted nature, it exhibits very low brain penetration, which enhances its safety profile compared to traditional opioid analgesics.

Other names
Anrikefon
02

Targets

CNR1 (Cannabinoid receptor 1)KOR (Kappa opioid receptor)

Beyond the preview

Go deeper on anrikefon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anrikefon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call